| Product Code: ETC13236391 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Antimicrobial Resistance Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Antimicrobial Resistance Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Africa Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Africa Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Antimicrobial Resistance Market Trends |
6 Africa Antimicrobial Resistance Market, 2021 - 2031 |
6.1 Africa Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021 - 2031 |
6.1.3 Africa Antimicrobial Resistance Market, Revenues & Volume, By Blood stream infections, 2021 - 2031 |
6.1.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021 - 2031 |
6.1.5 Africa Antimicrobial Resistance Market, Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021 - 2031 |
6.1.6 Africa Antimicrobial Resistance Market, Revenues & Volume, By Community acquired pneumonia (CAP), 2021 - 2031 |
6.1.7 Africa Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Combination therapies, 2021 - 2031 |
6.2.3 Africa Antimicrobial Resistance Market, Revenues & Volume, By Tetracyclines, 2021 - 2031 |
6.2.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Cephalosporins, 2021 - 2031 |
6.2.5 Africa Antimicrobial Resistance Market, Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021 - 2031 |
6.2.6 Africa Antimicrobial Resistance Market, Revenues & Volume, By Oxazolidinones, 2021 - 2031 |
6.2.7 Africa Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Africa Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Protein Synthesis Inhibitors, 2021 - 2031 |
6.3.3 Africa Antimicrobial Resistance Market, Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021 - 2031 |
6.3.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Klebsiella pneumoniae, 2021 - 2031 |
6.4.3 Africa Antimicrobial Resistance Market, Revenues & Volume, By Pseudomonas aeruginosa, 2021 - 2031 |
6.4.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Staphylococcus aureus, 2021 - 2031 |
6.4.5 Africa Antimicrobial Resistance Market, Revenues & Volume, By Enterococcus Spp, 2021 - 2031 |
6.4.6 Africa Antimicrobial Resistance Market, Revenues & Volume, By Escherichia coli, 2021 - 2031 |
6.4.7 Africa Antimicrobial Resistance Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Antimicrobial Resistance Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.1 South Africa Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.2 Egypt Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.3 Nigeria Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.4 Rest of Africa Antimicrobial Resistance Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3 Africa Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
7.3.1 South Africa Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.2 Egypt Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.3 Nigeria Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.4 Rest of Africa Antimicrobial Resistance Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 Africa Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.1 South Africa Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.2 Egypt Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.3 Nigeria Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.4.4 Rest of Africa Antimicrobial Resistance Market, Revenues & Volume, By Mechanism of Action, 2021 - 2031 |
7.5 Africa Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5.1 South Africa Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5.2 Egypt Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5.3 Nigeria Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5.4 Rest of Africa Antimicrobial Resistance Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
8 Africa Antimicrobial Resistance Market Key Performance Indicators |
9 Africa Antimicrobial Resistance Market - Export/Import By Countries Assessment |
10 Africa Antimicrobial Resistance Market - Opportunity Assessment |
10.1 Africa Antimicrobial Resistance Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.3 Africa Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.4 Africa Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10.5 Africa Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
11 Africa Antimicrobial Resistance Market - Competitive Landscape |
11.1 Africa Antimicrobial Resistance Market Revenue Share, By Companies, 2022 |
11.2 Africa Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here